Rituxan Approved to Treat Severe Pemphigus Vulgaris

The U.S. Food and Drug Administration has approved Genentech’s Rituxan (rituximab) to treat moderate-tosevere phemphigus vulgaris.

FDA Approves Fast-Acting, Single-Dose Flu Medication

The U.S. Food and Drug Administration (FDA) has approved a new, single-dose medication to treat people 12 years and older who have had the flu for no more than 48 hours.

First EpiPen Generics Get FDA Approval

FDA has approved the first generic versions of Mylan’s EpiPen and EpiPen Jr.

Study Shows Newborns’ Immune Systems Ramp Up After Birth

A new study shows newborns’ immune systems ramp up immediately after birth.

FDA Approves HPV Vaccine for 27- to 45-Year-Old Men and Women

Merck’s Gardasil 9 human papillomavirus (HPV) vaccine has been approved by the U.S. Food and Drug Administration (FDA) for an expanded indication for men and women between the ages of 27 years and 45 years.

Study Finds Vaccines Don’t Weaken Babies’ Immune Systems

Researchers conducted a study that examined whether the childhood vaccine schedule was associated with an increased risk of infections not targeted by vaccines.

Study Finds Mumps Vaccine Protection Wanes Over Time

A recent meta-analysis of six studies of mumps vaccine effectiveness conducted in the U.S. found protection against mumps lasts an average of 27 years after the last dose of the vaccine.

Study Finds Asthma Treatments for Kids More Likely to Fail Without Flu Shot

New research shows an annual influenza (flu) shot is crucial for children with asthma.

CDC OKs FluMist for 2018-19 Influenza Season

The Centers for Disease Control and Prevention’s advisory committee has voted 12-2 to recommend FluMist, the nasal spray version of the influenza vaccine, be used during the 2018-19 influenza (flu) season.

Cell-Based and Recombinant Vaccines More Effective in 2017-18 Flu Season

New data shows cell-based and recombinant vaccines were more effective in the 2017-18 influenza (flu) season